A Phase 2 Dose-escalation Study Examining the Safety, Pharmacokinetics, and Preliminary Efficacy of Ascending Drug and Energy Dose Combinations for Sonodynamic Therapy Using SONALA-001 in Combination with Exablate 4000 Type 2.0 MR-Guided Focused Ultrasound in Subjects with Diffuse Intrinsic Pontine Glioma (DIPG) and Diffuse Midline Glioma (DMG)
Latest Information Update: 26 Sep 2024
Price :
$35 *
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Diffuse intrinsic pontine glioma
- Focus Adverse reactions; First in man; Proof of concept
- Sponsors SonALAsense
- 10 Sep 2024 Planned End Date changed from 12 Aug 2025 to 30 Oct 2024.
- 10 Sep 2024 Status changed from discontinued to suspended.
- 02 Aug 2024 Status changed from active, no longer recruiting to discontinued due to lack of funding.